Construction and characterization of virG (icsA)-deleted Escherichia coli K12-Shigella flexneri hybrid vaccine strains

By Alexander W.A.   Hartman A.B.   Oaks E.V.   Venkatesan M.M.  

Vaccine, Vol. 14, Iss. 11, 1996-08 ,pp. : 1053-1061

Elsevier

Access to resources Recommend Favorite

guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

By Anderson R.J.   Pasetti M.F.   Sztein M.B.   Levine M.M.   Noriega F.R.  

Vaccine, Vol. 18, Iss. 21, 2000-04 ,pp. : 2193-2202

Elsevier

Access to resources Recommend Favorite

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2

By Kotloff K.L.   Losonsky G.A.   Nataro J.P.   Wasserman S.S.   Hale T.L.   Taylor D.N.   Newland J.W.   Sadoff J.C.   Formal S.B.   Levine M.M.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 495-502

Elsevier

Access to resources Recommend Favorite

Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers

By Vaughn D.W.   Hoke C.H.   Yoksan S.   LaChance R.   Innis B.L.   Rice R.M.   Bhamarapravati N.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 329-336

Elsevier

Access to resources Recommend Favorite

The two amino acid substitutions in the L protein of cpts530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations

By Juhasz K.   Whitehead S.S.   Boulanger C.A.   Firestone C.-Y.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1416-1424

Elsevier

Access to resources Recommend Favorite